Recently, the functional role of macrophage-derived AnxA1 in modulating hepatic inflammation and fibrogenesis during nonalcoholic steatohepatitis (NASH) progression was documented [68]. This evidence concerns the gene ANXA1 and metabolic dysfunction-associated steatohepatitis.